Minor hallucinations occur in drug‐naive Parkinson's disease patients, even from the premotor phase J Pagonabarraga, S Martinez‐Horta, R Fernández de Bobadilla, J Pérez, ... Movement Disorders 31 (1), 45-52, 2016 | 228 | 2016 |
Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's disease S Martinez-Horta, J Perez-Perez, E Van Duijn, R Fernandez-Bobadilla, ... Parkinsonism & related disorders 25, 58-64, 2016 | 159 | 2016 |
Apathy in Parkinson's disease: neurophysiological evidence of impaired incentive processing S Martínez-Horta, J Riba, RF de Bobadilla, J Pagonabarraga, ... Journal of Neuroscience 34 (17), 5918-5926, 2014 | 153* | 2014 |
Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale J Kulisevsky, RF de Bobadilla, J Pagonabarraga, S Martínez-Horta, ... Parkinsonism & related disorders 19 (9), 812-817, 2013 | 100 | 2013 |
Parkinson's disease‐cognitive rating scale: Psychometrics for mild cognitive impairment R Fernandez de Bobadilla, J Pagonabarraga, S Martínez‐Horta, ... Movement Disorders 28 (10), 1376-1383, 2013 | 92 | 2013 |
Validación de la versión española del test Addenbrooke's Cognitive Examination III para el diagnóstico de demencia JA Matias-Guiu, RF de Bobadilla, G Escudero, J Pérez-Pérez, A Cortés, ... Neurologia 30 (9), 545-551, 2015 | 90 | 2015 |
Clinical manifestations of intermediate allele carriers in Huntington disease E Cubo, MA Ramos-Arroyo, S Martinez-Horta, A Martínez-Descalls, ... Neurology 87 (6), 571-578, 2016 | 55 | 2016 |
Non-demented Parkinson’s disease patients with apathy show decreased grey matter volume in key executive and reward-related nodes S Martinez-Horta, F Sampedro, J Pagonabarraga, R Fernandez-Bobadilla, ... Brain imaging and behavior 11, 1334-1342, 2017 | 52 | 2017 |
Normative data for the Spanish version of the Addenbrooke's Cognitive Examination III JA Matías-Guiu, R Fernández-Bobadilla, A Fernández-Oliveira, ... Dementia and geriatric cognitive disorders 41 (5-6), 243-250, 2016 | 45 | 2016 |
Neurophysiological evidence of compensatory brain mechanisms in early-stage multiple sclerosis M López-Góngora, A Escartín, S Martinez-Horta, R Fernandez-Bobadilla, ... PloS one 10 (8), e0136786, 2015 | 41 | 2015 |
Parkinson's disease: impulsivity does not cause impulse control disorders but boosts their severity J Marín-Lahoz, J Pagonabarraga, S Martinez-Horta, ... Frontiers in psychiatry 9, 465, 2018 | 35 | 2018 |
Relationship between CYP2D6 Genotype and Haloperidol Pharmacokinetics and Extrapyramidal Symptoms in Healthy Volunteers P Gassó, K Papagianni, S Mas, RF De Bobadilla, JA Arnaiz, M Bernardo, ... Pharmacogenomics 14 (13), 1551-1563, 2013 | 33 | 2013 |
Head-to-head comparison of the neuropsychiatric effect of dopamine agonists in Parkinson’s disease: a prospective, cross-sectional study in non-demented patients J Pérez-Pérez, J Pagonabarraga, S Martínez-Horta, ... Drugs & Aging 32, 401-407, 2015 | 30 | 2015 |
Validation of the Spanish-language version of Mini-Addenbrooke's Cognitive Examination as a dementia screening tool JA Matias-Guiu, R Fernandez-Bobadilla Neurologia (Barcelona, Spain) 31 (9), 646-648, 2016 | 28 | 2016 |
Clinical and genetic characteristics of late-onset Huntington's disease M Oosterloo, EK Bijlsma, SM Van Kuijk, F Minkels, CEM de Die-Smulders Parkinsonism & related disorders 61, 101-105, 2019 | 27 | 2019 |
Secondary nonmotor negative symptoms in healthy volunteers after single doses of haloperidol and risperidone: a double‐blind, crossover, placebo‐controlled trial S Mas, P Gassó, R Fernandez de Bobadilla, JA Arnaiz, M Bernardo, ... Human Psychopharmacology: Clinical and Experimental 28 (6), 586-593, 2013 | 27 | 2013 |
Spanish REGISTRY investigators of the European Huntington’s Disease Network, Kulisevsky J. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington’s … S Martinez-Horta, J Perez-Perez, E van Duijn, R Fernandez-Bobadilla, ... Parkinsonism Relat Disord 25, 58-64, 2016 | 25 | 2016 |
Effect of CYP2D6 on Risperidone Pharmacokinetics and Extrapyramidal Symptoms in Healthy Volunteers: Results from a Pharmacogenetic Clinical Trial P Gasso, S Mas, K Papagianni, E Ferrando, RF De Bobadilla, JA Arnaiz, ... Pharmacogenomics 15 (1), 17-28, 2014 | 19 | 2014 |
Alterations in cerebral white matter and neuropsychology in patients with cirrhosis and falls B Gómez-Ansón, E Roman, R Fernández de Bobadilla, P Pires-Encuentra, ... PLoS One 10 (3), e0118930, 2015 | 17 | 2015 |
Parkinson's Disease—Cognitive Functional Rating Scale across different conditions and degrees of cognitive impairment E Ruzafa-Valiente, R Fernández-Bobadilla, C García-Sánchez, ... Journal of the neurological sciences 361, 66-71, 2016 | 15 | 2016 |